PuSH - Publikationsserver des Helmholtz Zentrums München

Syed, A.P. ; Greulich, F. ; Ansari, S.A. ; Uhlenhaut, N.H.

Anti-inflammatory glucocorticoid action: Genomic insights and emerging concepts.

Curr. Opin. Pharmacol. 53, 35-44 (2020)
Verlagsversion DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
Glucocorticoids (GCs) are widely used immunomodulators. They regulate gene expression by binding and activating the Glucocorticoid Receptor (GR), but underlying transcriptional mechanisms remain enigmatic. This review summarizes recent findings identifyingspecific GR-bound DNA sequences whose configuration may affect transcriptional output. Additional factors affecting GR's anti-inflammatory actions, including different chromatin states such as DNAse hypersensitive regions and histone marks will be discussed, together with the relevant transcriptional co-regulators and promoter/enhancer features. Furthermore, the involvement of non-coding RNAs such as lncRNAs, miRNAs and eRNAs adds another level of regulation to the GR's transcriptional activity. Characterizing and understanding these multiple mechanisms will be crucial for developing more targeted immunomodulatory therapies with reduced adverse effects such as obesity, diabetes and osteoporosis.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Korrespondenzautor
Schlagwörter Dna-binding; Chromatin Accessibility; Receptor Structure; Nuclear Receptors; Kappa-b; Transcription; Repression; Gr; Activation; Mechanisms
ISSN (print) / ISBN 1471-4892
e-ISSN 1471-4973
Zeitschrift Current opinion in pharmacology
Quellenangaben Band: 53, Heft: , Seiten: 35-44 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort London
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Cancer (IDC)
Förderungen Entzuendungsprozesse
DFG
ERC